Protective effect of chrysin, a flavonoid, on the genotoxic activity of carboplatin in mice

References

• Abdel-Daim, M.M., et al., 2019. The nephroprotective effects of allicin and ascorbic acid against cisplatin-induced toxicity in rats. Environmental Science and Pollution Research, 26 (13), 13502–13509
   PubMed Web of Science ®Google Scholar
• Acton, Q., 2013. Bone marrow cells-advances in research and application. Scholarly Editions, Atlanta, Georgia.
   Google Scholar
• Antunes, L., Darin, J., and Bianchi, M., 1999. Anticlastogenic effect of vitamin c on cisplatin in vivo. Genetics and Molecular Biology, 22 (3), 415–417.
   Web of Science ®Google Scholar
• Arafa, S.A., AboEl-El, M.M., and Kassem, H.S., 2008. Study of the genotoxic effect of cyclophosphamide on albino mice bone-marrow polychromatic erythrocytes and the protective effect of captopril. Bulletin of Alexandria Faculty of Medicine, 44, 821–828.
   Google Scholar
• Araldi, R.P., et al., 2015. Using the comet and micronucleus assays for genotoxicity studies: a review. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 72, 74–82.
   PubMed Web of Science ®Google Scholar
• Banerjee, S., and Chakravarty, A.R., 2015. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity. Accounts of Chemical Research, 48 (7), 2075–2083.
   PubMed Web of Science ®Google Scholar
• Cadet, J., 2014. Oxidative degradation pathways of cellular DNA: product formation and mechanistic insights. Free Radical Biology and Medicine, 75, S2.
   PubMed Web of Science ®Google Scholar
• Cadet, J., et al., 2003. Oxidative damage to DNA: formation, measurement and biochemical features. Mutation Research, 531 (1-2), 5–23.
   PubMed Web of Science ®Google Scholar
• Caruso, F., et al., 2012. Ruthenium-arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene)Ru(curcuminato)chloro . Journal of Medicinal Chemistry, 55 (3), 1072–1081.
   PubMed Web of Science ®Google Scholar
• Collins, A.R., and Azqueta, A., 2012. DNA repair as a biomarker in human biomonitoring studies; further applications of the comet assay. Mutation Research, 736 (1-2), 122–129.
   PubMed Web of Science ®Google Scholar
• Fong, C., 2016. Platinum anti-cancer drugs: free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect. Free Radical Biology & Medicine, 95, 216–229.
   PubMed Web of Science ®Google Scholar
• Freireich, E.J., et al., 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Reports, 50 (4), 219–244.
   PubMedGoogle Scholar
• Fuertes, M.A., Alonso, C., and Pérez, J.M., 2003. Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chemical Reviews, 103 (3), 645–662.
   PubMed Web of Science ®Google Scholar
• Gao, A.M., et al., 2013. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway. Chemico-Biological Interactions, 206 (1), 100–108.
   PubMed Web of Science ®Google Scholar
• Hagar, H., et al., 2015. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats. Experimental and Toxicologic Pathology, 67 (2), 133–141.
   PubMedGoogle Scholar
• Ibrahim, A., et al., 2018. Nephroprotective effects of benzyl isothiocyanate and resveratrol against cisplatin-induced oxidative stress and inflammation. Frontiers in Pharmacology, 9, 1268. doi:10.3389/fphar.2018.01268.
   PubMed Web of Science ®Google Scholar
• Ibrahim, A., Eldaim, M.A.A., and Abdel-Daim, M.M., 2016. Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats. Cytotechnology, 68 (4), 1039–1048. doi:10.1007/s10616-015-9860-2.
   PubMed Web of Science ®Google Scholar
• Ince, S., et al., 2014. Protective effect of polydatin, a natural precursor of resveratrol, against cisplatin-induced toxicity in rats. Food and Chemical Toxicology, 72, 147–153.
   PubMed Web of Science ®Google Scholar
• Johnstone, T.C., Suntharalingam, K., and Lippard, S.J., 2016. The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs. Chemical Reviews, 116 (5), 3436–3486.
   PubMed Web of Science ®Google Scholar
• Kandioller, W., et al., 2013. Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity. Chemical Communications (Cambridge, England), 49 (32), 3348–3350.
   PubMed Web of Science ®Google Scholar
• Kasala, E.R., et al., 2015. Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicology Letters, 233 (2), 214–225.
   PubMed Web of Science ®Google Scholar
• Knox, R.J., et al., 1986. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum (II) and cis-diammine-(1,1-cyclobutanedicarboxylato) platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Research, 46 (4 Pt 2), 1972–1979.
   PubMed Web of Science ®Google Scholar
• Koyuncu, I., et al., 2017. The protective effect of naringenin-oxime on cisplatin-induced toxicity in rats. Biochemistry Research International, 2017, 1–9.
   Web of Science ®Google Scholar
• Li, S., et al., 2015. The role of oxidative stress and antioxidants in liver diseases. International Journal of Molecular Sciences, 16 (11), 26087–26124.
   PubMed Web of Science ®Google Scholar
• Mani, R., and Natesan, V., 2018. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry, 145, 187–196.
   PubMed Web of Science ®Google Scholar
• Mora, L., et al., 2002. The effects of oral glutamine on cisplatin-induced genotoxicity in wistar rat bone marrow cells. Mutation Research, 518 (1), 65–70.
   PubMed Web of Science ®Google Scholar
• Nadin, S.B., et al., 2006. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy. Cancer Letters, 239 (1), 84–97.
   PubMed Web of Science ®Google Scholar
• Nimse, S., and Pal, D., 2015. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Advances, 5 (35), 27986–28006.
   Web of Science ®Google Scholar
• Pan, H., et al., 2014. Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice. PLoS One, 9 (1), e86057.
   PubMed Web of Science ®Google Scholar
• Pascoe, J.M., and Roberts, J., 2005. Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. Drug Resist Update, 8 (3), 131–146.
   PubMed Web of Science ®Google Scholar
• Pascoe, J.M., and Roberts, J.J., 1974. Interactions between mammalian cell DNA and inorganic platinum compounds. I. DNA interstrand cross-linking and cytotoxic properties of platinum (II) compounds. Biochemical Pharmacology, 23 (9), 1359–1365.
   PubMed Web of Science ®Google Scholar
• Preston, R.J., et al., 1987. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells. Mutation Research, 189 (2), 157–165.
   PubMed Web of Science ®Google Scholar
• Pushpavalli, G., et al., 2010. Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats. European Journal of Pharmacology, 631 (1-3), 36–41.
   PubMed Web of Science ®Google Scholar
• Rabik, C.A., and Dolan, M.E., 2007. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treatment Reviews, 33 (1), 9–23.
   PubMed Web of Science ®Google Scholar
• Razavi-Azarkhiavi, K., et al., 2016. The protective role of phenolic compounds against doxorubicin-induced cardiotoxicity: a comprehensive review. Nutrition and Cancer, 68 (6), 892–917.
   PubMed Web of Science ®Google Scholar
• Reuter, S., et al., 2010. Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology & Medicine, 49 (11), 1603–1616.
   PubMed Web of Science ®Google Scholar
• Rosenberg, B., et al., 1969. Platinum compounds: a new class of potent antitumour agents. Nature, 222 (5191), 385–386.
   PubMed Web of Science ®Google Scholar
• Schmid, W., 1976. The micronucleus test for cytogenetic analysis. In: A. Hollaender (ed.), Chemical mutagens: principles and methods for their detection. Vol. 4. New York: Plenum Press, pp. 31–53.
   Google Scholar
• Shi, L., et al., 1994. Premature p34cdc2 activation required for apoptosis. Science, 263 (5150), 1143–1145.
   PubMed Web of Science ®Google Scholar
• Shin, E.K., et al., 2009. Chrysin, a natural flavone, improves murine inflammatory bowel diseases. Biochemical and Biophysical Research Communications, 381 (4), 502–507.
   PubMed Web of Science ®Google Scholar
• Singh, N.P., et al., 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research., 175 (1), 184–191.
   PubMed Web of Science ®Google Scholar
• Travis, L., et al., 1996. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Research, 56 (7), 1564–1570.
   PubMed Web of Science ®Google Scholar
• Treml, J., and Smejkal, K., 2016. Flavonoids as potent scavengers of hydroxyl radicals. Comprehensive Reviews in Food Science and Food Safety, 15 (4), 720–738.
   PubMed Web of Science ®Google Scholar
• Wakabayashi, T., Kawashima, T., and Matsuzawa, Y., 2014. Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapy. Multidisciplinary Respiratory Medicine, 9 (1), 44.
   PubMedGoogle Scholar
• Wang, D., and Lippard, S.J., 2005. Cellular processing of platinum anticancer drugs. Nature reviews. Drug Discovery, 4 (4), 307–320.
   PubMed Web of Science ®Google Scholar